Pricing
Login
Home
Charts
Search
Watchlist
Products

Sai Life Sciences Ltd

SAILIFE
NSE
₹1,751.50-2.71%17 Nov 2026
Reports
Pharma CRAMS

Sai Life Sciences Ltd

SAILIFE
NSE
₹1,751.50
-2.71%
17 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹37,234Cr
Close
Close Price
₹1,751.50
Industry
Industry
Pharma CRAMS
PE
Price To Earnings
98.45
PS
Price To Sales
15.70
Revenue
Revenue
₹2,371Cr
Rev Gr TTM
Revenue Growth TTM
15.50%
PAT Gr TTM
PAT Growth TTM
31.36%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
384439280396440580496537556602554659
Growth YoY
Revenue Growth YoY%
14.631.977.535.926.53.911.722.5
Expenses
ExpensesCr
287315254293320422375392369426406472
Operating Profit
Operating ProfitCr
9612526102120158121146188177148186
OPM
OPM%
25.128.49.325.827.227.224.427.133.829.326.728.3
Other Income
Other IncomeCr
113810910101501644
Interest Expense
Interest ExpenseCr
232121212311129108811
Depreciation
DepreciationCr
313131363437384044454648
PBT
PBTCr
5376-1855721198111213413998131
Tax
TaxCr
1320-5141831202834352533
PAT
PATCr
4056-1442548860841001047398
Growth YoY
PAT Growth YoY%
36.057.3547.9102.086.418.121.217.3
NPM
NPM%
10.312.8-4.810.512.215.212.215.618.017.313.214.9
EPS
EPS₹
2.231.0-0.72.22.94.22.94.04.84.93.54.6
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
384439280396440580496537556602554659
Growth YoY
Revenue Growth YoY%
14.631.977.535.926.53.911.722.5
Expenses
ExpensesCr
287315254293320422375392369426406472
Operating Profit
Operating ProfitCr
9612526102120158121146188177148186
OPM
OPM%
25.128.49.325.827.227.224.427.133.829.326.728.3
Other Income
Other IncomeCr
113810910101501644
Interest Expense
Interest ExpenseCr
232121212311129108811
Depreciation
DepreciationCr
313131363437384044454648
PBT
PBTCr
5376-1855721198111213413998131
Tax
TaxCr
1320-5141831202834352533
PAT
PATCr
4056-1442548860841001047398
Growth YoY
PAT Growth YoY%
36.057.3547.9102.086.418.121.217.3
NPM
NPM%
10.312.8-4.810.512.215.212.215.618.017.313.214.9
EPS
EPS₹
2.231.0-0.72.22.94.22.94.04.84.93.54.6

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6957267608701,2171,4651,6952,1922,371
Growth
Revenue Growth%
4.44.714.440.020.415.729.415.5
Expenses
ExpensesCr
5225605957471,0521,1801,2891,5611,673
Operating Profit
Operating ProfitCr
173165165123165285406631699
OPM
OPM%
24.922.821.614.113.619.523.928.829.5
Other Income
Other IncomeCr
61827282829374123
Interest Expense
Interest ExpenseCr
211930517786763936
Depreciation
DepreciationCr
4455809099119139167183
PBT
PBTCr
113109821016109228466503
Tax
TaxCr
403321362658117126
PAT
PATCr
73766161083170349376
Growth
PAT Growth%
3.9-19.9-89.860.4729.0105.5105.131.4
NPM
NPM%
10.610.58.00.70.85.710.015.915.9
EPS
EPS₹
51.546.635.13.60.64.68.816.617.8
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6957267608701,2171,4651,6952,1922,371
Growth
Revenue Growth%
4.44.714.440.020.415.729.415.5
Expenses
ExpensesCr
5225605957471,0521,1801,2891,5611,673
Operating Profit
Operating ProfitCr
173165165123165285406631699
OPM
OPM%
24.922.821.614.113.619.523.928.829.5
Other Income
Other IncomeCr
61827282829374123
Interest Expense
Interest ExpenseCr
211930517786763936
Depreciation
DepreciationCr
4455809099119139167183
PBT
PBTCr
113109821016109228466503
Tax
TaxCr
403321362658117126
PAT
PATCr
73766161083170349376
Growth
PAT Growth%
3.9-19.9-89.860.4729.0105.5105.131.4
NPM
NPM%
10.610.58.00.70.85.710.015.915.9
EPS
EPS₹
51.546.635.13.60.64.68.816.617.8

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
161617181818212121
Reserves
ReservesCr
7037778458618709572,1072,4632,667
Current Liabilities
Current LiabilitiesCr
3364675997137597407328341,185
Non Current Liabilities
Non Current LiabilitiesCr
160149356565540560299309329
Total Liabilities
Total LiabilitiesCr
1,2151,4101,8172,1572,1872,2753,1603,6264,202
Current Assets
Current AssetsCr
6916138049449649451,5051,4111,441
Non Current Assets
Non Current AssetsCr
5257981,0141,2131,2231,3301,6552,2162,762
Total Assets
Total AssetsCr
1,2151,4101,8172,1572,1872,2753,1603,6264,202
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
161617181818212121
Reserves
ReservesCr
7037778458618709572,1072,4632,667
Current Liabilities
Current LiabilitiesCr
3364675997137597407328341,185
Non Current Liabilities
Non Current LiabilitiesCr
160149356565540560299309329
Total Liabilities
Total LiabilitiesCr
1,2151,4101,8172,1572,1872,2753,1603,6264,202
Current Assets
Current AssetsCr
6916138049449649451,5051,4111,441
Non Current Assets
Non Current AssetsCr
5257981,0141,2131,2231,3301,6552,2162,762
Total Assets
Total AssetsCr
1,2151,4101,8172,1572,1872,2753,1603,6264,202

Cash Flow

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
129116-36105219263314509
Investing Cash Flow
Investing Cash FlowCr
-158-262-260-104-102-192-537-395
Financing Cash Flow
Financing Cash FlowCr
268-429672-201-95301-124
Net Cash Flow
Net Cash FlowCr
239-150-175-83-2579-10
Free Cash Flow
Free Cash FlowCr
-28-157-298-10214882-55-83
CFO To PAT
CFO To PAT%
175.7151.3-59.51,684.22,196.4317.7184.6145.9
CFO To EBITDA
CFO To EBITDA%
74.670.0-22.185.5133.092.277.480.7
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
129116-36105219263314509
Investing Cash Flow
Investing Cash FlowCr
-158-262-260-104-102-192-537-395
Financing Cash Flow
Financing Cash FlowCr
268-429672-201-95301-124
Net Cash Flow
Net Cash FlowCr
239-150-175-83-2579-10
Free Cash Flow
Free Cash FlowCr
-28-157-298-10214882-55-83
CFO To PAT
CFO To PAT%
175.7151.3-59.51,684.22,196.4317.7184.6145.9
CFO To EBITDA
CFO To EBITDA%
74.670.0-22.185.5133.092.277.480.7

Ratios

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
15,88320,55437,234
Price To Earnings
Price To Earnings
93.458.998.5
Price To Sales
Price To Sales
9.49.415.7
Price To Book
Price To Book
7.58.313.8
EV To EBITDA
EV To EBITDA
38.932.959.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
62.561.760.957.154.560.464.165.165.1
OPM
OPM%
24.922.821.614.113.619.523.928.829.5
NPM
NPM%
10.610.58.00.70.85.710.015.915.9
ROCE
ROCE%
14.211.97.53.75.110.312.318.217.2
ROE
ROE%
10.29.67.10.71.18.58.014.114.0
ROA
ROA%
6.05.43.40.30.53.65.49.68.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
15,88320,55437,234
Price To Earnings
Price To Earnings
93.458.998.5
Price To Sales
Price To Sales
9.49.415.7
Price To Book
Price To Book
7.58.313.8
EV To EBITDA
EV To EBITDA
38.932.959.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
62.561.760.957.154.560.464.165.165.1
OPM
OPM%
24.922.821.614.113.619.523.928.829.5
NPM
NPM%
10.610.58.00.70.85.710.015.915.9
ROCE
ROCE%
14.211.97.53.75.110.312.318.217.2
ROE
ROE%
10.29.67.10.71.18.58.014.114.0
ROA
ROA%
6.05.43.40.30.53.65.49.68.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Pharma CRAMS
Market CapitalizationMkt CapCr2,95,9971,26,32552,07937,23432,28132,04627,514
Close PriceClose₹11,150.002,338.00924.251,751.503,942.90240.7021,445.00
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE87.9894.2084.7298.4573.5160.80
Price To SalesPS24.2816.1525.4515.7020.273.2811.93
RevenueRevenueCr12,1917,8232,0462,3711,5939,7792,307
Revenue Growth TTMRev Gr TTM%21.6%23.0%-1.2%15.5%45.2%9.4%50.5%
PAT Growth TTMPAT Gr TTM%35.3%96.3%18.9%31.4%95.8%-782.0%88.4%
Market CapitalizationMkt CapCr2,95,9971,26,32552,07937,23432,28132,04627,514
Close PriceClose₹11,150.002,338.00924.251,751.503,942.90240.7021,445.00
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE87.9894.2084.7298.4573.5160.80
Price To SalesPS24.2816.1525.4515.7020.273.2811.93
RevenueRevenueCr12,1917,8232,0462,3711,5939,7792,307
Revenue Growth TTMRev Gr TTM%21.6%23.0%-1.2%15.5%45.2%9.4%50.5%
PAT Growth TTMPAT Gr TTM%35.3%96.3%18.9%31.4%95.8%-782.0%88.4%